Cefotaxime Sodium

CAS 64485-93-4 9 current records 4 historicalSmall Molecule

Who holds supplier records for Cefotaxime Sodium? 9 organisations hold a current record for Cefotaxime Sodium: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (3), India (2), Italy (1), Germany (1) and 2 other countries (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cefotaxime Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cefotaxime-sodium

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cefotaxime Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • ACS DOBFAR SPA
    Active DMF 14367 · latest filing Aug 1999
    ItalyCEP Company GMP cert on record
  • Orchid Pharma Limited
    Active DMF 17888 · latest filing Dec 2004
    IndiaCEP Company GMP cert on record
  • Shandong Anhong Pharmaceutical Co., Ltd.
    Active DMF 41732 · latest filing Apr 2025
    ChinaCEP Company GMP cert on record
  • Ceph Lifesciences Private Limited
    Active DMF 24748 · latest filing Mar 2011
    India
  • Sandoz GmbH
    Active DMF 21202 · latest filing Dec 2007
    Germany Company GMP cert on record
  • Kyongbo Pharmaceutical Co., Ltd.
    Inactive DMF 24793 · latest filing Mar 2011
    SouthCEP
  • Qilu Antibiotics Pharmaceutical Co., Ltd.
    ChinaCEP Company GMP cert on record
  • HANMI FINE CHEMICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    South KoreaCEP
  • NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Cefotaxime Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (7)

Certificates of Suitability on the EDQM register for Cefotaxime Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHANDONG ANHONG PHARMACEUTICAL CO., LTD. DezhouCN
CEP 2024-318 - Rev 01
Cefotaxime sodium, Sterile
Jun 2026Inspected Nov 2025
Greece
QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. JinanCN
CEP 2020-406 - Rev 01
Cefotaxime sodium, Sterile, Process 2
May 2025Inspected Jun 2026
Austria
ORCHID PHARMA LIMITED AlathurIN
CEP 1999-033 - Rev 04
Cefotaxime sodium, Sterile
Oct 2024Inspected Oct 2024
Poland
HANMI FINE CHEMICAL CO., LTD. Siheung-siKR
CEP 1999-161 - Rev 06
Cefotaxime sodium, Sterile; process D
May 2024—
NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD. ShijiazhuangCN
CEP 2014-197 - Rev 01
Cefotaxime sodium, Sterile
Jan 2024Inspected Sept 2023
Germany, outside 3-year window
KYONGBO PHARMACEUTICAL CO., LTD. Asan-siKR
R1-CEP 2006-224 - Rev 04
Cefotaxime sodium, Sterile
Jul 2022—
ACS DOBFAR S.P.A. TribianoIT
R1-CEP 1998-050 - Rev 03
Cefotaxime sodium, Sterile
Feb 2008—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Cefotaxime Sodium are no longer active. These show a past filing, not current supply.

Show all 4 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Cefotaxime Sodium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1010).

Chemical identity

IUPAC name
sodium (6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Canonical SMILES
CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]
InChIKey
AZZMGZXNTDTSME-JUZDKLSSSA-M
Synonyms
Cefcil, Cefotaxime sodium, Cefotaxime sodium salt, Claforan, HR 756, HR-756, NSC-756666, Pretor, RU 24756, RU-24756, Sodium cefotaxime

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cephalosporin Antibacterial
Chemical structure
Cephalosporins

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cefotaxime Sodium?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Cefotaxime Sodium: ACS DOBFAR SPA (Italy), Orchid Pharma Limited (India), Shandong Anhong Pharmaceutical Co., Ltd. (China), Ceph Lifesciences Private Limited (India), Sandoz GmbH (Germany), Kyongbo Pharmaceutical Co., Ltd. (South), Qilu Antibiotics Pharmaceutical Co., Ltd. (China) and HANMI FINE CHEMICAL CO., LTD. (South Korea), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cefotaxime Sodium Drug Master Files are active?

ACS DOBFAR SPA (DMF 14367), Orchid Pharma Limited (DMF 17888), Shandong Anhong Pharmaceutical Co., Ltd. (DMF 41732), Ceph Lifesciences Private Limited (DMF 24748) and Sandoz GmbH (DMF 21202). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cefotaxime Sodium records mean?

4 organisations have only inactive Type II DMFs for Cefotaxime Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Cefotaxime Sodium have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Cefotaxime Sodium on the EDQM register, including SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou (CN), QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. Jinan (CN), ORCHID PHARMA LIMITED Alathur (IN), HANMI FINE CHEMICAL CO., LTD. Siheung-si (KR), NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD. Shijiazhuang (CN) and KYONGBO PHARMACEUTICAL CO., LTD. Asan-si (KR) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Cefotaxime Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cefotaxime Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.